(Q33942081)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10852127%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

review article

1 reference

title

Antibodies in human infectious disease (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10852127%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10852127%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

author name string

P W Parren

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10852127%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

P Poignard

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10852127%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

R A Williamson

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10852127%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

D R Burton

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10852127%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

publication date

1 January 2000

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10852127%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10852127%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

volume

21

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10852127%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

page(s)

265-278

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10852127%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

issue

2-3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10852127%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1385/ir:21:2-3:265

7 November 2019

exact match

0 references

cites work

HIV-1 neutralizing antibodies: how full is the bottle?

1 reference

12 December 2020

Structural clues to prion replication

1 reference

12 December 2020

Human monoclonal Fab fragments derived from a combinatorial library bind to respiratory syncytial virus F glycoprotein and neutralize infectivity

1 reference

12 December 2020

Physical studies of conformational plasticity in a recombinant prion protein

1 reference

12 December 2020

Neutralizing antibodies have limited effects on the control of established HIV-1 infection in vivo.

1 reference

12 December 2020

Neutralization of animal viruses

1 reference

12 December 2020

Structure of the recombinant full-length hamster prion protein PrP(29-231): the N terminus is highly flexible

1 reference

12 December 2020

HIV entry and its inhibition

1 reference

12 December 2020

Correlation analysis between frequencies of circulating antigen-specific IgG-bearing memory B cells and serum titers of antigen-specific IgG

1 reference

12 December 2020

Passive immunization with a human monoclonal antibody protects hu-PBL-SCID mice against challenge by primary isolates of HIV-1.

1 reference

12 December 2020

Human immunodeficiency virus type 1 mutants that escape neutralization by human monoclonal antibody IgG1b12. off.

1 reference

12 December 2020

Recognition properties of a panel of human recombinant Fab fragments to the CD4 binding site of gp120 that show differing abilities to neutralize human immunodeficiency virus type 1.

1 reference

12 December 2020

Antibody neutralization-resistant primary isolates of human immunodeficiency virus type 1.

1 reference

12 December 2020

Assembly of combinatorial antibody libraries on phage surfaces: the gene III site

1 reference

12 December 2020

Inhibition of virus attachment to CD4+ target cells is a major mechanism of T cell line-adapted HIV-1 neutralization

1 reference

12 December 2020

Mapping the protein surface of human immunodeficiency virus type 1 gp120 using human monoclonal antibodies from phage display libraries

1 reference

12 December 2020

Recombinant human monoclonal antibodies to Ebola virus

1 reference

12 December 2020

Jitters jeopardize AIDS vaccine trials

1 reference

12 December 2020

Erratum to "Relevance of the antibody response against human immunodeficiency virus type 1 envelope to vaccine design".

1 reference

12 December 2020

NMR structure of the mouse prion protein domain PrP(121-231)

1 reference

12 December 2020

Eight prion strains have PrP(Sc) molecules with different conformations

1 reference

12 December 2020

A large array of human monoclonal antibodies to type 1 human immunodeficiency virus from combinatorial libraries of asymptomatic seropositive individuals

1 reference

12 December 2020

Cellular biology of prion diseases

1 reference

12 December 2020

HIV-1 neutralization: the consequences of viral adaptation to growth on transformed T cells.

1 reference

12 December 2020

Human monoclonal antibody 2G12 defines a distinctive neutralization epitope on the gp120 glycoprotein of human immunodeficiency virus type 1

1 reference

12 December 2020

Neutralization of human immunodeficiency virus type 1 by antibody to gp120 is determined primarily by occupancy of sites on the virion irrespective of epitope specificity

1 reference

12 December 2020

A vaccine for HIV type 1: the antibody perspective

1 reference

12 December 2020

NMR characterization of the full-length recombinant murine prion protein, mPrP(23-231).

1 reference

12 December 2020

Protection against HIV-1 infection in hu-PBL-SCID mice by passive immunization with a neutralizing human monoclonal antibody against the gp120 CD4-binding site.

1 reference

12 December 2020

Recombinant human respiratory syncytial virus (RSV) monoclonal antibody Fab is effective therapeutically when introduced directly into the lungs of RSV-infected mice

1 reference

12 December 2020

Ebola virus can be effectively neutralized by antibody produced in natural human infection

1 reference

12 December 2020

A conformational transition at the N terminus of the prion protein features in formation of the scrapie isoform

1 reference

12 December 2020

Conversion of alpha-helices into beta-sheets features in the formation of the scrapie prion proteins

1 reference

12 December 2020

The same prion strain causes vCJD and BSE

1 reference

12 December 2020

Stoichiometry of monoclonal antibody neutralization of T-cell line-adapted human immunodeficiency virus type 1

1 reference

12 December 2020

In vitro antigen challenge of human antibody libraries for vaccine evaluation: the human immunodeficiency virus type 1 envelope

1 reference

12 December 2020

Humoral immunity due to long-lived plasma cells.

1 reference

12 December 2020

Molecular analysis of prion strain variation and the aetiology of 'new variant' CJD.

1 reference

12 December 2020

A conserved neutralizing epitope on gp41 of human immunodeficiency virus type 1

1 reference

12 December 2020

Human immunodeficiency virus type 1 neutralization is determined by epitope exposure on the gp120 oligomer

1 reference

12 December 2020

Transmission dynamics and epidemiology of BSE in British cattle

1 reference

12 December 2020

Efficient neutralization of primary isolates of HIV-1 by a recombinant human monoclonal antibody

1 reference

12 December 2020

HIV-1 antibody--debris or virion?

1 reference

12 December 2020

Neutralizing antibody directed against the HIV-1 envelope glycoprotein can completely block HIV-1/SIV chimeric virus infections of macaque monkeys.

1 reference

12 December 2020

Human antibody responses to mature and immature forms of viral envelope in respiratory syncytial virus infection: significance for subunit vaccines

1 reference

12 December 2020

The neutralizing antibody response to HIV-1: viral evasion and escape from humoral immunity

1 reference

12 December 2020

Protection of Macaques against pathogenic simian/human immunodeficiency virus 89.6PD by passive transfer of neutralizing antibodies.

1 reference

12 December 2020

Human monoclonal antibodies against a plethora of viral pathogens from single combinatorial libraries.

1 reference

12 December 2020

Protein misfolding and prion diseases

1 reference

12 December 2020

Requirement for multiple lymphocyte subsets in protection by a live attenuated vaccine against retroviral infection

1 reference

12 December 2020

Neutralizing antibodies administered before, but not after, virulent SHIV prevent infection in macaques.

1 reference

12 December 2020

Antibodies against HIV-1 from phage display libraries: mapping of an immune response and progress towards antiviral immunotherapy.

1 reference

12 December 2020

The new variant form of Creutzfeldt-Jakob disease

1 reference

12 December 2020

Transmissions to mice indicate that 'new variant' CJD is caused by the BSE agent

1 reference

12 December 2020

Antibody binding defines a structure for an epitope that participates in the PrPC-->PrPSc conformational change

1 reference

12 December 2020

Why do we not have an HIV vaccine and how can we make one? .

1 reference

12 December 2020